Skip to main content
Premium Trial:

Request an Annual Quote

Americans Fear Genetic Discrimination, But Support Tests and Research, Johns Hopkins Survey Finds

NEW YORK (GenomeWeb News) — While an overwhelming majority of Americans support the use of genetic testing for medical conditions, an equal number fears employers or health care companies can misuse information from such tests in discriminatory ways, according to a Johns Hopkins University white paper.
 
According to the document, which reports results of a survey conducted by the school’s Genetics and Public Policy Center, more than 90 percent of Americans support researchers and doctors using genetic tests for research, for predicting reactions to medical treatments, and for identifying risk for treating disease.
 
But 93 percent of responders also said employers and health insurers should not be able to use personal genetic information to make decisions about workplace hiring or promotions, or about insurance limitations or pricing.
 
More than 75 percent of those surveyed supported a law that would protect Americans from employers and health insurers using genetic tests to make such decisions.
 
“Despite widespread, longstanding agreement among American citizens and politicians that protection from genetic discrimination should be clear and consistent, an individual’s genetic information is protected only by a largely untested patchwork of state and federal regulations,” according to the white paper.
 
The paper, which can be found here, said “many states have enacted protections” against genetic discrimination in health insurance, employment, or both, though these laws “vary widely in scope and many are untested in court.” State laws “fail to provide a uniform floor of protections in employment and health insurance on which Americans can rely,” according to the white paper.
  
When responders to the GPPC survey were asked how much they trust different people with their personal genetic test results, most said they would trust doctors, spouses, and genetics researchers. However, only 24 percent said they would trust health insurers with access to such tests, and only 16 percent would trust their employers with this information.
 
The center released the findings in a statement saying the survey was conducted in anticipation of an upcoming congressional vote on a bill, the Genetic Information Non-discrimination Act, designed to protect individuals from discrimination based on information from genetic tests.
 
The bill, known as GINA, is currently waiting for a vote in the US House of Representatives.

The Scan

Drug Response Variants May Be Distinct in Somatic, Germline Samples

Based on variants from across 21 drug response genes, researchers in The Pharmacogenomics Journal suspect that tumor-only DNA sequences may miss drug response clues found in the germline.

Breast Cancer Risk Gene Candidates Found by Multi-Ancestry Low-Frequency Variant Analysis

Researchers narrowed in on new and known risk gene candidates with variant profiles for almost 83,500 individuals with breast cancer and 59,199 unaffected controls in Genome Medicine.

Health-Related Quality of Life Gets Boost After Microbiome-Based Treatment for Recurrent C. Diff

A secondary analysis of Phase 3 clinical trial data in JAMA Network Open suggests an investigational oral microbiome-based drug may lead to enhanced quality of life measures.

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.